Therefore, this pilot study aimed to assess whether serial NT-proBNP measurements may influence treatment decisions, such as dose adjustments of prognostically beneficial HF medication, and outcomes in patients hospitalized for ADHF. The gene discussed is NPPB; the disease is hydrops fetalis.